av/profound-medical--big.svg

NASDAQ:PROF

Profound Medical

  • Stock

USD

Last Close

6.93

01/05 19:59

Market Cap

298.03M

Beta: 1.26

Volume Today

6.07K

Avg: 24.14K

PE Ratio

−6.25

PFCF: −8.27

    Description

    Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scann...Show More

    Earnings

    Earnings per Share (Estimate*)

    -0.6-0.4-0.20.20.42018-05-102020-03-032021-11-042023-08-092024-10-31

    Revenue (Estimate*)

    1M2M3M4M2018-05-102020-03-032021-11-042023-08-092024-10-31

    *Estimate based on analyst consensus